Author:
Vural Gülin,Özalp Elçin,Çalikoğlu Tamer,Üçer Ali Riza,Durmuş Sema,Turgut Bülent,Erçakmak Nur
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference30 articles.
1. Bonadonna G, Valagussa P. Adjuvant chemoendocrine therapy in breast cancer.J Clin Oncol 1986; 4: 451–454.
2. Early Breast Cancer Trials’ Collaborative Group. Effect of adjuvant tamoxifen and cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28896 women.N Engl J Med 1988; 319:1681–1692.
3. Gregory MS, Frederick LM, Kevin D, Mohammed MM, Kimberley CC, David SR, et al. Total axillary lymphadenec-tomy in the management of breast cancer.Arch Surg 1991; 126: 1336–1342.
4. Osborne CK, Clark GM, Ravdin PM. Adjuvant systemic therapy of primary breast cancer. In: Harris Lippmann ME, Morrow M, Helman S, eds.Disease of the breast. Philadelphia; J.B. Lippincott, 1996: 548–578.
5. Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, et al. Complications of axillary lymph node dissection for carcinoma of the breast: A report based on a patient survey.American Cancer Society 1998; 38 (7): 1362–1368.